Last reviewed · How we verify
Bryophyllum p. — Competitive Intelligence Brief
marketed
Herbal/botanical preparation
Dermatology; Wound Care
Small molecule
Live · refreshed every 30 min
Target snapshot
Bryophyllum p. (Bryophyllum p.) — Weleda AG. Bryophyllum pinnatum extract promotes wound healing and tissue regeneration through anti-inflammatory and hemostatic properties.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bryophyllum p. TARGET | Bryophyllum p. | Weleda AG | marketed | Herbal/botanical preparation | ||
| Phyllanthus niruri | Phyllanthus niruri | Rosenberg European Academy of Ayurveda | marketed | Herbal/botanical preparation | ||
| caraway oil | caraway oil | Universität Duisburg-Essen | marketed | Herbal/botanical preparation |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Herbal/botanical preparation class)
- Rosenberg European Academy of Ayurveda · 1 drug in this class
- Universität Duisburg-Essen · 1 drug in this class
- Weleda AG · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bryophyllum p. CI watch — RSS
- Bryophyllum p. CI watch — Atom
- Bryophyllum p. CI watch — JSON
- Bryophyllum p. alone — RSS
- Whole Herbal/botanical preparation class — RSS
Cite this brief
Drug Landscape (2026). Bryophyllum p. — Competitive Intelligence Brief. https://druglandscape.com/ci/bryophyllum-p. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab